0
0
0
Therapeutic Fraud Prevention Act of 2021
12/31/2022, 4:58 AM
Summary of Bill HR 4146
Bill 117 HR 4146, also known as the Therapeutic Fraud Prevention Act of 2021, aims to address the issue of fraudulent practices in the field of conversion therapy. Conversion therapy, also known as reparative therapy, is a controversial practice that claims to change an individual's sexual orientation or gender identity.
The bill specifically targets practitioners who engage in deceptive practices by advertising or providing services that claim to change an individual's sexual orientation or gender identity. It prohibits any person or entity from advertising or providing conversion therapy services in exchange for monetary compensation.
Furthermore, the bill requires the Federal Trade Commission to enforce these provisions and investigate any complaints of fraudulent conversion therapy practices. It also allows individuals who have been harmed by conversion therapy to seek civil remedies in court. Overall, the Therapeutic Fraud Prevention Act of 2021 seeks to protect vulnerable individuals from being deceived by fraudulent conversion therapy practices and hold practitioners accountable for their actions.
The bill specifically targets practitioners who engage in deceptive practices by advertising or providing services that claim to change an individual's sexual orientation or gender identity. It prohibits any person or entity from advertising or providing conversion therapy services in exchange for monetary compensation.
Furthermore, the bill requires the Federal Trade Commission to enforce these provisions and investigate any complaints of fraudulent conversion therapy practices. It also allows individuals who have been harmed by conversion therapy to seek civil remedies in court. Overall, the Therapeutic Fraud Prevention Act of 2021 seeks to protect vulnerable individuals from being deceived by fraudulent conversion therapy practices and hold practitioners accountable for their actions.
Congressional Summary of HR 4146
Therapeutic Fraud Prevention Act of 2021
This bill prohibits commercial conversion therapy, which is a practice or treatment designed to change a person's sexual orientation or gender identity or otherwise change behaviors, thoughts, or expressions related to gender or sexual attraction. This prohibition does not apply to treatment that assists an individual undergoing a gender transition or facilitates identity exploration and development.
Read the Full Bill
Current Status of Bill HR 4146
Bill HR 4146 is currently in the status of Bill Introduced since June 24, 2021. Bill HR 4146 was introduced during Congress 117 and was introduced to the House on June 24, 2021. Bill HR 4146's most recent activity was Referred to the Subcommittee on Consumer Protection and Commerce. as of June 25, 2021
Bipartisan Support of Bill HR 4146
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
394Democrat Cosponsors
394Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4146
Primary Policy Focus
CommercePotential Impact Areas
- Civil actions and liability
- Consumer affairs
- Marketing and advertising
- Mental health
- Sex and reproductive health
- Sex, gender, sexual orientation discrimination
- Social work, volunteer service, charitable organizations
- State and local government operations
Alternate Title(s) of Bill HR 4146
To prohibit commercial sexual orientation conversion therapy, and for other purposes.
Therapeutic Fraud Prevention Act of 2021
Therapeutic Fraud Prevention Act of 2021
Comments
Sponsors and Cosponsors of HR 4146
Latest Bills
Protecting Families from AI Data Center Energy Costs Act
Bill HR 6529August 1, 2026
Prices on the Wall Act of 2026
Bill HR 9390August 1, 2026
Pipeline Safety Authorization Act of 2026
Bill HR 9338August 1, 2026
Ratepayer Protection Act
Bill HR 9340August 1, 2026
Tyler’s Law
Bill HR 2004August 1, 2026
Stop Pills That Kill Act
Bill HR 8005August 1, 2026
Load Forecasting Enhancement Act
Bill HR 9332August 1, 2026
EMRTAI Authorization Act of 2026
Bill HR 9616August 1, 2026
High-Capacity Grid Act
Bill HR 6633August 1, 2026
Combating Illicit Xylazine Act
Bill HR 1266August 1, 2026
Therapeutic Fraud Prevention Act of 2021
Bill S 2242December 30, 2022




